SWOG/ Support |
STUDY | R E G |
O P E N |
ARM | ACCR. GOAL |
TOTAL REGS. |
REGS. LAST 12 Month |
REGS. LAST 6 Month |
REGS. LAST 3 Month |
REGS. LAST 30 DAYS |
REGS. LAST 7 DAYS |
DATE OF FIRST REG. |
# of ACT. INSTs |
# of CURR IRBs |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SWOG | S1827-SCLC, MRI Surveillance +/- PCI | 1 | Y | 1 PCI + MRI brain surveillance | 668 | 113 | 34 | 19 | 8 | 2 | 0 | 05/04/2020 | 338 | 129 |
2 MRI brain surveillance | 115 | 36 | 22 | 8 | 3 | 0 | ||||||||
228 | 70 | 41 | 16 | 5 | 0 | |||||||||
S1914-NSCLC, High Risk Early Stg, SBRT +/- Atezo | 1 | Y | 1 Atezolizumab and SBRT | 480 | 197 | 83 | 47 | 20 | 9 | 2 | 08/13/2020 | 362 | 131 | |
2 SBRT | 192 | 80 | 39 | 22 | 3 | 0 | ||||||||
389 | 163 | 86 | 42 | 12 | 2 | |||||||||
S1933-NSCLC, Stg II-III, RT + Atezo | 1 | Y | 1 Hypofractionated Radiotherapy | 47 | 39 | 10 | 6 | 3 | 1 | 0 | 01/13/2021 | 117 | 43 | |
39 | 10 | 6 | 3 | 1 | 0 | |||||||||
2 | Y | 2 Atezolizumab | 29 | 6 | 4 | 0 | 0 | 0 | 01/13/2021 | |||||
29 | 6 | 4 | 0 | 0 | 0 | |||||||||
S2302-NSCLC, Stg IV or Recur, Ramu + Pembro vs SoC | 1 | Y | 1 Standard of Care (Inv. Choice) | 700 | 271 | 241 | 130 | 55 | 15 | 2 | 03/14/2023 | 472 | 192 | |
2 Ramucirumab + Pembrolizumab | 274 | 240 | 133 | 61 | 18 | 4 | ||||||||
545 | 481 | 263 | 116 | 33 | 6 | |||||||||
LUNGMAP-NSCLC, Adv, Master | 0 | N | 0 ctDNA Specimen Submission | 315 | 0 | 0 | 0 | 0 | 0 | 02/06/2019 | 424 | 178 | ||
315 | 0 | 0 | 0 | 0 | 0 | |||||||||
1 | Y | 1 Biomarker Profiling | 3420 | 313 | 158 | 76 | 28 | 9 | 02/06/2019 | |||||
3420 | 313 | 158 | 76 | 28 | 9 | |||||||||
2 | Y | 10 S1800D | 516 | 0 | 0 | 0 | 0 | 0 | ||||||
11 S1900F | 2 | 0 | 0 | 0 | 0 | 0 | ||||||||
12 S1900G | 20 | 17 | 7 | 3 | 1 | 0 | ||||||||
13 S1900K | 3 | 3 | 3 | 1 | 0 | 0 | ||||||||
2 S1400F | 31 | 0 | 0 | 0 | 0 | 0 | 02/06/2019 | |||||||
4 S1800A | 653 | 0 | 0 | 0 | 0 | 0 | ||||||||
5 S1900A | 101 | 0 | 0 | 0 | 0 | 0 | ||||||||
6 S1900B | 13 | 0 | 0 | 0 | 0 | 0 | ||||||||
7 S1900C | 101 | 0 | 0 | 0 | 0 | 0 | ||||||||
9 S1900E | 235 | 38 | 15 | 8 | 2 | 0 | ||||||||
1675 | 58 | 25 | 12 | 3 | 0 | |||||||||
3 | Y | 22 S1400F | 3 | 0 | 0 | 0 | 0 | 0 | 02/06/2019 | |||||
24 S1800A | 14 | 0 | 0 | 0 | 0 | 0 | ||||||||
26 S1900B | 1 | 0 | 0 | 0 | 0 | 0 | ||||||||
27 S1900C | 4 | 0 | 0 | 0 | 0 | 0 | ||||||||
29 S1900E | 3 | 0 | 0 | 0 | 0 | 0 | ||||||||
30 S1800D | 25 | 0 | 0 | 0 | 0 | 0 | ||||||||
31 S1900F | 1 | 0 | 0 | 0 | 0 | 0 | ||||||||
51 | 0 | 0 | 0 | 0 | 0 | |||||||||
4 | Y | 49 S1900E | 1 | 0 | 0 | 0 | 0 | 0 | 02/06/2019 | |||||
1 | 0 | 0 | 0 | 0 | 0 | |||||||||
Yes | A081801-ALCHEMIST4, ALK and EGFR negative, Chemo-IO | 1 | E | Total Registrations | 79 | 17 | 10 | 4 | 3 | 2 | 10/20/2020 | 413 | 173 | |
79 | 17 | 10 | 4 | 3 | 2 | |||||||||
A151216-ALCHEMIST0 - screening | 1 | E | Total Registrations | 976 | 26 | 9 | 2 | 1 | 0 | 12/16/2014 | 511 | 238 | ||
976 | 26 | 9 | 2 | 1 | 0 | |||||||||
EA5162-NSCLS,StgIV/IIB,EGFR exon20 insertion,AZD9291 | 1 | E | Total Registrations | 1 | 1 | 0 | 0 | 0 | 0 | 08/23/2023 | 84 | 39 | ||
1 | 1 | 0 | 0 | 0 | 0 | |||||||||
EA5182-NSCLC, Met EGFR mut, AZD9291+Beva vs AZD9291 | 1 | E | Total Registrations | 17 | 9 | 7 | 3 | 0 | 0 | 04/28/2021 | 183 | 81 | ||
17 | 9 | 7 | 3 | 0 | 0 | |||||||||
NRGLU008-Lung NSCL, StgII-III, StereoBodyRad/MedChemo | 1 | E | Total Registrations | 1 | 1 | 1 | 0 | 0 | 0 | 01/26/2024 | 31 | 11 | ||
1 | 1 | 1 | 0 | 0 | 0 | |||||||||
No | A082002-Lung, Adv, Systemic Tx +/- SBRT | 1 | E | Total Registrations | 4 | 1 | 1 | 0 | 0 | 0 | 10/12/2022 | 207 | 64 | |
4 | 1 | 1 | 0 | 0 | 0 | |||||||||
A151216-ALCHEMIST0 - screening | 0 | E | Total Registrations | 990 | 28 | 8 | 2 | 0 | 0 | 12/16/2014 | 511 | 238 | ||
990 | 28 | 8 | 2 | 0 | 0 | |||||||||
Study | Registration/Phase | Open Date | # of ACT. INSTs |
# of CURR IRBs |
---|---|---|---|---|
LUNGMAP NSCLC, Adv, Master | 5 Sub-study Assignment IV | 28-Jan-19 | 424 | 178 |